FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078761720> ?p ?o ?g. }

• W2078761720 endingPage "701" @default.
• W2078761720 startingPage "696" @default.
• W2078761720 abstract "Reduction of intraocular pressure by 20-30% with glaucoma drainage surgery slows disease progression in normal tension glaucoma (NTG). It is not clear whether adjunctive antiproliferative agents are necessary or safe in eyes at low risk for scarring.61 eyes of 61 white patients with NTG who had undergone a primary guarded fistulising procedure were reviewed. 20 eyes had no antiproliferatives (nil), 29 had peroperative 5-fluorouracil (5-FU), and 12 had peroperative mitomycin C (MMC). Pointwise linear regression analysis (PROGRESSOR for Windows software) was applied to their visual field series starting with the first visual field following surgery and adding subsequent visual fields one at a time. Progression of visual field loss was defined as the appearance of a regression slope 1 dB per year or more with a significance of p<0.01 at one or more visual field locations which remained consistent with the addition of two of three successive visual fields. Time updated covariate analysis was used to determine the relation between variables that changed with time, such as IOP, and the risk of progression.The median percentage IOP reduction was 24.4 for the nil group, 38.0 for the 5-FU group, and 47.5 for the MMC group (p=0.001). There was a statistically significant relation between percentage change in IOP and risk of visual field progression in the subsequent 6 month period for all patients analysed as one group, hazard ratio = -0.021 (p=0.002). There was a statistically significantly increase in the risk of visual field progression for the MMC group compared with the 5-FU group, hazard ratio = 1.51 (p=0.02).In NTG patients, the IOP reduction produced by drainage surgery reduces the risk that visual field progression may be reduced after drainage surgery; this is related to the level of IOP reduction. The percentage drop in IOP during a given time is related to the risk of subsequent visual field progression. However, the use of MMC is associated with a greater risk of visual field progression despite a greater fall in IOP. This visual field deterioration may be related to the functional loss produced by late postoperative complications which have been reported at a higher rate in this group. The use of adjunctive perioperative 5-FU should maintain a suitable target IOP with preservation of visual function without the additional complications and associated visual deterioration seen with adjunctive MMC." @default.
• W2078761720 created "2016-06-24" @default.
• W2078761720 creator A5021232284 @default.
• W2078761720 creator A5043640338 @default.
• W2078761720 creator A5043890577 @default.
• W2078761720 creator A5053626373 @default.
• W2078761720 creator A5069032977 @default.
• W2078761720 date "2001-06-01" @default.
• W2078761720 modified "2023-09-25" @default.
• W2078761720 title "Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression" @default.
• W2078761720 cites W1968811682 @default.
• W2078761720 cites W1971307050 @default.
• W2078761720 cites W1973720349 @default.
• W2078761720 cites W1981450446 @default.
• W2078761720 cites W1992216996 @default.
• W2078761720 cites W2007162049 @default.
• W2078761720 cites W2011051456 @default.
• W2078761720 cites W2019610144 @default.
• W2078761720 cites W2020819672 @default.
• W2078761720 cites W2027735427 @default.
• W2078761720 cites W2042098225 @default.
• W2078761720 cites W2053212314 @default.
• W2078761720 cites W2054462224 @default.
• W2078761720 cites W2074362238 @default.
• W2078761720 cites W2080645218 @default.
• W2078761720 cites W2088191999 @default.
• W2078761720 cites W2089291688 @default.
• W2078761720 cites W2097671029 @default.
• W2078761720 cites W2104525090 @default.
• W2078761720 cites W2145587966 @default.
• W2078761720 cites W2160599258 @default.
• W2078761720 cites W2203097267 @default.
• W2078761720 cites W2322543443 @default.
• W2078761720 cites W2401995575 @default.
• W2078761720 cites W54973665 @default.
• W2078761720 cites W2007146569 @default.
• W2078761720 doi "https://doi.org/10.1136/bjo.85.6.696" @default.
• W2078761720 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1724011" @default.
• W2078761720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11371491" @default.
• W2078761720 hasPublicationYear "2001" @default.
• W2078761720 type Work @default.
• W2078761720 sameAs 2078761720 @default.
• W2078761720 citedByCount "61" @default.
• W2078761720 countsByYear W20787617202013 @default.
• W2078761720 countsByYear W20787617202014 @default.
• W2078761720 countsByYear W20787617202015 @default.
• W2078761720 countsByYear W20787617202016 @default.
• W2078761720 countsByYear W20787617202017 @default.
• W2078761720 countsByYear W20787617202018 @default.
• W2078761720 countsByYear W20787617202020 @default.
• W2078761720 countsByYear W20787617202021 @default.
• W2078761720 countsByYear W20787617202023 @default.
• W2078761720 crossrefType "journal-article" @default.
• W2078761720 hasAuthorship W2078761720A5021232284 @default.
• W2078761720 hasAuthorship W2078761720A5043640338 @default.
• W2078761720 hasAuthorship W2078761720A5043890577 @default.
• W2078761720 hasAuthorship W2078761720A5053626373 @default.
• W2078761720 hasAuthorship W2078761720A5069032977 @default.
• W2078761720 hasBestOaLocation W20787617201 @default.
• W2078761720 hasConcept C118487528 @default.
• W2078761720 hasConcept C126322002 @default.
• W2078761720 hasConcept C141071460 @default.
• W2078761720 hasConcept C2776058522 @default.
• W2078761720 hasConcept C2776766258 @default.
• W2078761720 hasConcept C2777824320 @default.
• W2078761720 hasConcept C2778527774 @default.
• W2078761720 hasConcept C2780179686 @default.
• W2078761720 hasConcept C2781092963 @default.
• W2078761720 hasConcept C2991803831 @default.
• W2078761720 hasConcept C50440223 @default.
• W2078761720 hasConcept C71924100 @default.
• W2078761720 hasConceptScore W2078761720C118487528 @default.
• W2078761720 hasConceptScore W2078761720C126322002 @default.
• W2078761720 hasConceptScore W2078761720C141071460 @default.
• W2078761720 hasConceptScore W2078761720C2776058522 @default.
• W2078761720 hasConceptScore W2078761720C2776766258 @default.
• W2078761720 hasConceptScore W2078761720C2777824320 @default.
• W2078761720 hasConceptScore W2078761720C2778527774 @default.
• W2078761720 hasConceptScore W2078761720C2780179686 @default.
• W2078761720 hasConceptScore W2078761720C2781092963 @default.
• W2078761720 hasConceptScore W2078761720C2991803831 @default.
• W2078761720 hasConceptScore W2078761720C50440223 @default.
• W2078761720 hasConceptScore W2078761720C71924100 @default.
• W2078761720 hasIssue "6" @default.
• W2078761720 hasLocation W20787617201 @default.
• W2078761720 hasLocation W20787617202 @default.
• W2078761720 hasLocation W20787617203 @default.
• W2078761720 hasLocation W20787617204 @default.
• W2078761720 hasLocation W20787617205 @default.
• W2078761720 hasOpenAccess W2078761720 @default.
• W2078761720 hasPrimaryLocation W20787617201 @default.
• W2078761720 hasRelatedWork W1949172687 @default.
• W2078761720 hasRelatedWork W1971004186 @default.
• W2078761720 hasRelatedWork W2020156363 @default.
• W2078761720 hasRelatedWork W2064676060 @default.
• W2078761720 hasRelatedWork W2266293505 @default.
• W2078761720 hasRelatedWork W2752872894 @default.
• W2078761720 hasRelatedWork W275622479 @default.

• next